The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer

Carcinogenesis

Volumn 30, Issue 2, 2009, Pages 295-299

  Gao, Lin Bo ^a   Rao, Li ^b   Wang, Yan Yun ^a   Liang, Wei Bo ^a   Li, Cui ^a   Xue, Hui ^a   Zhou, Bin ^c   Sun, Hong ^a   Li, Yi ^a   Lv, Mei Li ^a   Du, Xiao Jiong ^b   Zhang, Lin ^c  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 16;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

AGED; ALLELES; CHINA; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-16; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS;

EID: 60349111251     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn281     Document Type: Article

References (44)

1. Lu,H. et al. (2006) Inflammation, a key event in cancer development. Mol. Cancer Res., 4, 221-233.
2. Moss,S.F. et al. (2005) Mechanisms of disease: Inflammation and the origins of cancer. Nat. Clin. Pract. Oncol., 2, 90-97; quiz 1 p following 113.
3. Perwez Hussain,S. et al. (2007) Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer, 121, 2373-2380.
4. Itzkowitz,S.H. et al. (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 287 G7-G17.
5. Kundu,J.K. et al. (2008) Inflammation: Gearing the journey to cancer. Mutat. Res., 659, 15-30.
6. Mochizuki,Y. et al. (2004) TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin. Exp. Metastasis 21, 39-47.
7. Muc-Wierzgon,M. et al. (2006) Genetic disregulation of TNF alpha and TNF alpha type II receptors in colon cancer at the II and III stage of disease. J. Biol. Regul. Homeost. Agents, 20, 10-14.
8. Kai,H. et al. (2005) Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res., 25, 709-713.
9. Schneider,M.R. et al. (2000) Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett., 151, 31-38.
10. Chung,Y.C. et al. (2003) Serum interleukin-6 levels reflect the disease status of colorectal cancer. J. Surg. Oncol., 83, 222-226.
11. Shanmugham,L.N. et al. (2006) IL-15 an immunoregulatory and anticancer cytokine. Recent advances. J. Exp. Clin. Cancer Res., 25, 529-536.
12. Speetjens,F.M. et al. (2008) Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients. Clin. Cancer Res., 14, 2276-2284.
13. Kollmar,O. et al. (2007) Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 9, 862-870.
14. Huang,S.P. et al. (2005) Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J. Biomed. Sci., 12 229-241.
15. Center,D.M. et al. (1982) Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J. Immunol., 128, 2563-2568.
16. Kim,H.S. (1999) Assignment of human interleukin 16 (IL16) to chromosome 15q26.3 by radiation hybrid mapping. Cytogenet. Cell Genet., 84 93.
17. Baier,M. et al. (1997) Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc. Natl Acad. Sci. USA, 94, 5273-5277.
18. Drwinga,H.L. et al. (1993) NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2. Genomics, 16, 311-314.
19. Zhang,Y. et al. (1998) Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem., 273, 1144-1149.
20. Laberge,S. et al. (1995) Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. J. Immunol., 155, 2902-2910.
21. Rumsaeng,V. et al. (1997) Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J. Immunol., 159, 2904-2910.
22. Sharma,V. et al. (2000) Human B-cell lines constitutively express and secrete interleukin-16. Immunology, 99, 266-271.
23. Cruikshank,W.W. et al. (1994) Molecular and functional analysis of a lymphocyte chemoattractant factor: Association of biologic function with CD4 expression. Proc. Natl Acad. Sci. USA, 91, 5109-5113.
24. Center,D.M. et al. (1996) Interleukin 16 and its function as a CD4 ligand. Immunol. Today, 17, 476-481.
25. Mathy,N.L. et al. (2000) Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology, 100, 63-69.
26. Kovacs,E. (2001) The serum levels of IL-12 and IL-16 in cancer patients. Relation to the tumour stage and previous therapy. Biomed. Pharmacother., 55, 111-116.
27. Liebrich,M. et al. (2007) Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors. Arch. Immunol. Ther. Exp. (Warsz.), 55 41-47.
28. Koike,M. et al. (2002) Relationship between CD4(+)/CD8(+) T cell ratio and T cell activation in multiple myeloma: Reference to IL-16. Leuk. Res., 26, 705-711.
29. Alexandrakis,M.G. et al. (2004) Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity. Am. J. Hematol., 75, 101-106.
30. Thomas,G. et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet., 40, 310-315.
31. Passam,F.H. et al. (2008) Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment. Int. J. Lab. Hematol. 30, 17-25.
32. Blaschke,V. et al. (1999) Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides. J. Invest. Dermatol., 113, 658-663.
33. Ryan,T.C. et al. (1995) The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J. Biol. Chem., 270, 17081-17086.
34. Krautwald,S. (1998) IL-16 activates the SAPK signaling pathway in CD4+ macrophages. J. Immunol., 160, 5874-5879.
35. Gu,X.J. et al. (2008) Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease. Clin. Immunol., 127, 298-302.
36. Reich,K. et al. (2003) Association of allergic contact dermatitis with a promoter polymorphism in the IL16 gene. J. Allergy Clin. Immunol., 112, 1191-1194.
37. Burkart,K.M. et al. (2006) Association of asthma with a functional promoter polymorphism in the IL16 gene. J. Allergy Clin. Immunol., 117, 86-91.
38. Folwaczny,M. et al. (2005) Prevalence of the -295 T-to-C promoter polymorphism of the interleukin (IL)-16 gene in periodontitis. Clin. Exp. Immunol., 142, 188-192.
39. Glas,J. et al. (2003) The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin. Immunol., 106, 197-200.
40. Hong,J. et al. (2008) IL4, IL10, IL16, and TNF polymorphisms in New Zealand Caucasian Crohn's disease patients. Int. J. Colorectal Dis., 23, 335-337.
41. Akesson,L.S. et al. (2005) A polymorphism in the promoter region of the human interleukin-16 gene is not associated with asthma or atopy in an Australian population. Clin. Exp. Allergy, 35, 327-331.
42. Hosseini-Farahabadi,S. et al. (2007) Association between the polymorphisms of IL-4 gene promoter (-590C>T), IL-13 coding region (R130Q) and IL-16 gene promoter (-295T>C) and allergic asthma. Iran J. Allergy Asthma Immunol., 6, 9-14.
43. Nakayama,E.E. et al. (2000) A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes Immun., 1, 293-294.
44. Glass,W.G. et al. (2006) Not-so-sweet sixteen: The role of IL-16 in infectious and immune-mediated inflammatory diseases. J. Interferon Cytokine Res., 26, 511-520.